Powrózek Tomasz, Mlak Radosław, Dziedzic Marcin, Małecka-Massalska Teresa, Sagan Dariusz
Department of Human Physiology, Medical University of Lublin, Radziwiłłowska 11, 20-080, Lublin, Poland.
Department of Laboratory Diagnostic, Medical University of Lublin, Lublin, Poland.
J Cancer Res Clin Oncol. 2017 Oct;143(10):1941-1946. doi: 10.1007/s00432-017-2444-0. Epub 2017 May 24.
Because of the alarming data concerning lung cancer morbidity and mortality, investigation of new molecular markers allowing early cancer detection is desirable. In the present study, we investigated the potential role of miRNA-3662 precursor (pri-miRNA-3662) as potential novel diagnostic marker of lung adenocarcinoma (AC).
Expression of miRNA-3662 and pri-miRNA-3662 was analyzed in 56 fresh-frozen tissues of non-small cell lung cancer and corresponding adjacent non-cancerous tissues using (NCT) qRT-PCR. Using receiver operating curves (ROC) analysis, the diagnostic accuracy of both studied markers for AC detection was assessed.
miRNA-3662 and its precursor were significantly overexpressed in AC compared to squamous-cell carcinoma (SCC) and NCT. Combined analysis of pri-miRNA-3662 and mature miRNA-3662 allowed to distinguish AC tissue from SCC with sensitivity of 96% and specificity of 85.7% (AUC = 0.963), and SCC from non-cancerous tissue with 92% sensitivity and 92% specificity (AUC = 0.979).
miRNA-3662 and its precursor are potentially involved in AC development. pri-miRNA seem to be novel interesting group of potential cancer biomarkers, because they demonstrate high diagnostic accuracy for tumor detection.
鉴于肺癌发病率和死亡率的数据令人担忧,研究能够实现癌症早期检测的新分子标志物很有必要。在本研究中,我们调查了miRNA - 3662前体(pri - miRNA - 3662)作为肺腺癌(AC)潜在新型诊断标志物的作用。
使用qRT - PCR分析了56例非小细胞肺癌新鲜冷冻组织及其相应的癌旁非癌组织中miRNA - 3662和pri - miRNA - 3662的表达。通过绘制受试者工作特征曲线(ROC)分析,评估了这两种研究标志物对AC检测的诊断准确性。
与鳞状细胞癌(SCC)和癌旁非癌组织相比,miRNA - 3662及其前体在AC中显著过表达。对pri - miRNA - 3662和成熟miRNA - 3662进行联合分析,能够区分AC组织与SCC,灵敏度为96%,特异性为85.7%(AUC = 0.963);区分SCC与非癌组织,灵敏度为92%,特异性为92%(AUC = 0.979)。
miRNA - 3662及其前体可能参与了AC的发生发展。pri - miRNA似乎是一组潜在的新型有趣的癌症生物标志物,因为它们在肿瘤检测中显示出较高诊断准确性。